Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$4.27 - $6.97 $91,954 - $150,098
-21,535 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$5.31 - $8.25 $7,078 - $10,997
-1,333 Reduced 5.83%
21,535 $126,000
Q2 2021

Aug 11, 2021

BUY
$6.81 - $9.23 $155,731 - $211,071
22,868 New
22,868 $184,000
Q4 2020

Feb 16, 2021

SELL
$7.04 - $11.7 $122,496 - $203,580
-17,400 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$7.49 - $15.16 $130,326 - $263,784
17,400 New
17,400 $264,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.